ECM-receptor interaction was enriched based on the KEGG pathway in our study, while COL3A1, COL5A2, and COL2A1 were regarded as potential ECM components associated with cytostatic drug resistance in ovarian cancer cells [23]. Here, COL5A2 is linked to ovarian cancer.